Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
MSV-allo (Red de Terapia Celular)
- Development stage
- Unknown
- Lead developer
- Red de Terapia Celular
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intravenous
01
Overview
**MSV-allo** is an investigational, donor-derived mesenchymal stromal cell therapy developed by Red de Terapia Celular. The product consists of allogeneic bone-marrow-derived mesenchymal stem/stromal cells administered by intravenous infusion. It is intended to mitigate the dysregulated inflammatory response associated with severe COVID-19 pneumonia and acute respiratory failure through broad paracrine immunomodulatory, anti-inflammatory, and tissue-repair effects rather than through a single defined molecular target. MSV-allo was evaluated in the completed randomized, double-blind, placebo-controlled Phase I/II MSV-COVID study in severe COVID-19 pneumonia and is also in Phase II development for lupus nephritis.
- Other names
- MSV
Beyond the preview
Go deeper on MSV-allo (Red de Terapia Celular).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MSV-allo (Red de Terapia Celular).